Our Team

KS Lam, MD, PhD

University of California Davis, California

• Distinguished Professor, Department of Biochemistry & Molecular Medicine
• Inventor, OBOC combinatorial chemistry
• 30 years of clinical experience to treat cancer patients
• Leader in nanomedicine, drug development and combinatorial chemistry research

Shawn Mu, MBA, PhD

• Co-founder of 2 start-up companies in new drug development, including advanced drug delivery platforms and first-in-class small molecules
• Extensive experience in drug delivery and the generic drug industry, holding multiple patents in drug delivery technology
• Management experience at international pharma corporations such as Sanofi-Aventis and KV Pharma

Stephen Mason, PhD

• Twenty-five years of drug discovery and development experience on first-in-class small and large molecules
• Contributed to the discovery of nirmatrelvir, the anti-COVID-19 component of PAXLOVID
• Experience in both biotech and large pharma, such as Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, and J&J

Ruiwu Liu, PhD

Professional Researcher at UC Davis Cancer Center; Ph.D. in Medicinal Chemistry;

• Pioneered OBOC/OB2C combinatorial library methods for drug discovery,
• 100+ peer-reviewed articles (Nature Communications, JACS), 40+ on combinatorial chemistry,
• 6 patents, and 8 book chapters.